{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:36Z","timestamp":1787772156777,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11906-018-0854-2","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T04:56:04Z","timestamp":1528433764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Focused Update on Pharmacologic Management of Hypertensive Emergencies"],"prefix":"10.1007","volume":"20","author":[{"given":"Kristin","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Broscious","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Devabhakthuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"854_CR1","unstructured":"Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, et al. 2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. 2010;121(13):e266-e369."},{"key":"854_CR2","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex : 1979). 2017."},{"issue":"12","key":"854_CR3","doi-asserted-by":"publisher","first-page":"e004511","DOI":"10.1161\/JAHA.116.004511","volume":"5","author":"AT Janke","year":"2016","unstructured":"Janke AT, McNaughton CD, Brody AM, Welch RD, Levy PD. Trends in the incidence of hypertensive emergencies in US emergency departments from 2006 to 2013. J Am Heart Assoc. 2016;5(12):e004511.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"854_CR4","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.amjcard.2011.06.046","volume":"108","author":"A Deshmukh","year":"2011","unstructured":"Deshmukh A, Kumar G, Kumar N, Nanchal R, Gobal F, Sakhuja A, et al. Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. Am J Cardiol. 2011;108(9):1277\u201382.","journal-title":"Am J Cardiol"},{"issue":"7","key":"854_CR5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/ajh\/hpx048","volume":"30","author":"M Shah","year":"2017","unstructured":"Shah M, Patil S, Patel B, Arora S, Patel N, Garg L, et al. Trends in hospitalization for hypertensive emergency, and relationship of end-organ damage with in-hospital mortality. Am J Hypertens. 2017;30(7):700\u20136.","journal-title":"Am J Hypertens"},{"issue":"3","key":"854_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/jch.12058","volume":"15","author":"H Gonzalez Pacheco","year":"2013","unstructured":"Gonzalez Pacheco H, Morales Victorino N, Nunez Urquiza JP, Altamirano Castillo A, Juarez Herrera U, Arias Mendoza A, et al. Patients with hypertensive crises who are admitted to a coronary care unit: clinical characteristics and outcomes. J Clin Hypertens (Greenwich). 2013;15(3):210\u20134.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"15","key":"854_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2146\/ajhp080348.p1","volume":"66","author":"D Rhoney","year":"2009","unstructured":"Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm. 2009;66(15):1343\u201352.","journal-title":"Am J Health Syst Pharm"},{"issue":"16","key":"854_CR8","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.2146\/ajhp080348.p2","volume":"66","author":"D Rhoney","year":"2009","unstructured":"Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 2. Am J Health Syst Pharm. 2009;66(16):1448\u201357.","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"854_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/00000441-197412000-00004","volume":"268","author":"NM Keith","year":"1974","unstructured":"Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1974;268(6):336\u201345.","journal-title":"Am J Med Sci"},{"issue":"4","key":"854_CR10","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/AOG.0000000000002019","volume":"129","author":"Committee Opinion No. 692","year":"2017","unstructured":"Committee Opinion No. 692. Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2017;129(4):e90\u2013e5.","journal-title":"Obstet Gynecol"},{"key":"854_CR11","unstructured":"American College of O, Gynecologists, Task Force on Hypertension in P. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Available at: \n                      https:\/\/www.acog.org\/Clinical-Guidance-and-Publications\/Task_Force_and_Work_Group-Reports\/Hypertension-in-Pregnancy\n                      \n                     Accessed 10 Jan 2018."},{"issue":"4","key":"854_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/GRF.0000000000000063","volume":"57","author":"RB Vadhera","year":"2014","unstructured":"\u2022 Vadhera RB, Simon M. Hypertensive emergencies in pregnancy. Clin Obstet Gynecol. 2014;57(4):797\u2013805. A review of hypertensive emergencies during pregnancy, including definition, assessment, and treatment options.","journal-title":"Clin Obstet Gynecol"},{"issue":"7194","key":"854_CR13","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1136\/bmj.318.7194.1332","volume":"318","author":"LA Magee","year":"1999","unstructured":"Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ. 1999;318(7194):1332\u20136.","journal-title":"BMJ"},{"issue":"7421","key":"854_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","volume":"327","author":"LA Magee","year":"2003","unstructured":"Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955\u201360.","journal-title":"BMJ"},{"issue":"14","key":"854_CR15","first-page":"475","volume":"62","author":"GJ Vink","year":"1982","unstructured":"Vink GJ, Moodley J. The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy. S Afr Med J. 1982;62(14):475\u20137.","journal-title":"S Afr Med J"},{"issue":"5","key":"854_CR16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/AOG.0b013e3182a9ea68","volume":"122","author":"Shashank Shekhar","year":"2013","unstructured":"\u2022 Shekhar S, Sharma C, Thakur S, Verma S. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. Obstet Gynecol. 2013;122(5):1057\u201363. A double-blind, randomized, controlled trial of pregnant women with severe pre-eclampsia were given either oral immediate-release nifedipine or IV labetalol. Time to target blood pressure was not statistically significant between the two arms and there were no differences in serious side effects.","journal-title":"Obstetrics & Gynecology"},{"issue":"6","key":"854_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/jcpt.12439","volume":"41","author":"DD Shi","year":"2016","unstructured":"Shi DD, Yang FZ, Zhou L, Wang N. Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia. J Clin Pharm Ther. 2016;41(6):657\u201361.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"854_CR18","doi-asserted-by":"publisher","first-page":"687.e1","DOI":"10.1016\/j.ajog.2017.08.018","volume":"217","author":"C Sharma","year":"2017","unstructured":"\u2022 Sharma C, Soni A, Gupta A, Verma A, Verma S. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. Am J Obstet Gynecol. 2017;217(6):687.e1\u20136. A double-blinded, randomized, controlled trial of pregnant women with hypertensive emergency received either IV hydralazine or oral immediate release nifedipine. The time to target blood pressure was 40\u00a0min in each arm.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"854_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/uog.14836","volume":"47","author":"J Cornette","year":"2016","unstructured":"\u2022 Cornette J, Buijs EA, Duvekot JJ, Herzog E, Roos-Hesselink JW, Rizopoulos D, et al. Hemodynamic effects of intravenous nicardipine in severely pre-eclamptic women with a hypertensive crisis. Ultrasound Obstet Gynecol. 2016;47(1):89\u201395. A ten-patient study of nicardipine in pregnant women with pre-eclampsia evaluated both maternal hemodynamic changes and uteroplacental and fetal perfusion.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"854_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.gyobfe.2012.07.003","volume":"40","author":"G Carles","year":"2012","unstructured":"Carles G, Helou J, Alassas N, Dallah F, Ibrahim N. Complications of association magnesium sulfate with nicardipine during preeclampsia: report of 2 cases. Gynecol Obstet Fertil. 2012;40(10):614\u20136.","journal-title":"Gynecol Obstet Fertil"},{"issue":"4","key":"854_CR21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0002-9378(89)90779-5","volume":"161","author":"VM Parisi","year":"1989","unstructured":"Parisi VM, Salinas J, Stockmar EJ. Fetal vascular responses to maternal nicardipine administration in the hypertensive ewe. Am J Obstet Gynecol. 1989;161(4):1035\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"854_CR22","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/0002-9378(89)90780-1","volume":"161","author":"VM Parisi","year":"1989","unstructured":"Parisi VM, Salinas J, Stockmar EJ. Placental vascular responses to nicardipine in the hypertensive ewe. Am J Obstet Gynecol. 1989;161(4):1039\u201343.","journal-title":"Am J Obstet Gynecol"},{"key":"854_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejogrb.2015.02.002","volume":"189","author":"SW Bijvank","year":"2015","unstructured":"Bijvank SW, Visser W, Duvekot JJ, Steegers EA, Edens MA, Roofthooft DW, et al. Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015;189:106\u201311.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"854_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12028-013-9863-9","volume":"19","author":"X Liu-DeRyke","year":"2013","unstructured":"Liu-DeRyke X, Levy PD, Parker D Jr, Coplin W, Rhoney DH. A prospective evaluation of labetalol versus nicardipine for blood pressure management in patients with acute stroke. Neurocrit Care. 2013;19(1):41\u20137.","journal-title":"Neurocrit Care"},{"key":"854_CR25","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke - April 18, 2018. The revised, online version of the guideline is available at: \n                      http:\/\/stroke.ahajournals.org\/content\/49\/3\/e46\n                      \n                    ."},{"key":"854_CR26","doi-asserted-by":"crossref","unstructured":"\u2022 Allison TA, Bowman S, Gulbis B, Hartman H, Schepcoff S, Lee K. Comparison of clevidipine and nicardipine for acute blood pressure reduction in patients with stroke. J Intensive Care Med. 2017:885066617724340. A retrospective evaluation of patients receiving either clevidipine or nicardipine for acute ischemic or hemorrhagic stroke showed no difference in time to target blood pressure.","DOI":"10.1177\/0885066617724340"},{"issue":"25","key":"854_CR27","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","volume":"368","author":"CS Anderson","year":"2013","unstructured":"\u2022\u2022 Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355\u201365. An international, multicenter, open-label, randomized trial evaluated intense blood pressure control (SBP <\u2009140\u00a0mmHg) versus guideline-recommended treatment (SBP <\u2009180\u00a0mmHg) and found no difference in the primary endpoint of death or severe disability.","journal-title":"N Engl J Med"},{"issue":"11","key":"854_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","volume":"375","author":"AI Qureshi","year":"2016","unstructured":"\u2022\u2022 Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033\u201343. A multicenter, open-label, randomized trial evaluated intensive blood pressure control (SBP 110\u2013139\u00a0mm Hg) vs standard medical care (SBP <\u2009180\u00a0mmHg) and found no difference in the rate of death or disability between the two groups.","journal-title":"N Engl J Med"},{"issue":"7","key":"854_CR29","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","volume":"46","author":"JC Hemphill 3rd","year":"2015","unstructured":"Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015;46(7):2032\u201360.","journal-title":"Stroke"},{"issue":"3","key":"854_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000351149","volume":"36","author":"C Graffagnino","year":"2013","unstructured":"Graffagnino C, Bergese S, Love J, Schneider D, Lazaridis C, LaPointe M, et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial. Cerebrovasc Dis (Basel, Switzerland). 2013;36(3):173\u201380.","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"16","key":"854_CR31","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147\u2013239.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"854_CR32","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1136\/heartjnl-2015-307461","volume":"101","author":"DM Viau","year":"2015","unstructured":"\u2022\u2022 Viau DM, Sala-Mercado JA, Spranger MD, O'Leary DS, Levy PD. The pathophysiology of hypertensive acute heart failure. Heart. 2015;101(23):1861\u20137. A review of the pathophysiology of acute heart failure due to hypertensive emergency, including graphs and images of hemodynamic changes that occur.","journal-title":"Heart"},{"issue":"1","key":"854_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12245-016-0125-4","volume":"9","author":"SI Ayaz","year":"2016","unstructured":"\u2022 Ayaz SI, Sharkey CM, Kwiatkowski GM, Wilson SS, John RS, Tolomello R, et al. Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department. Int J Emerg Med. 2016;9(1):28. This study was a retrospective review of patients with heart failure who received intravenous (IV) enalaprilat; treatment was associated with a significant reduction in blood pressure but an increase in adverse effects at 72\u00a0h.","journal-title":"Int J Emerg Med"},{"issue":"4","key":"854_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ahj.2013.12.023","volume":"167","author":"WF Peacock","year":"2014","unstructured":"\u2022 Peacock WF, Chandra A, Char D, Collins S, Der Sahakian G, Ding L, et al. Clevidipine in acute heart failure: results of the a study of blood pressure control in acute heart failure\u2013a pilot study (PRONTO). Am Heart J. 2014;167(4):529\u201336. A randomized, open-label study evaluating IV clevidipine vs standard care in patients presenting with acute heart failure and hypertensive emergency showed that patients receiving clevidipine reached target blood pressure faster and had greater improvement in symptoms.","journal-title":"Am Heart J"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-018-0854-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0854-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0854-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T19:21:19Z","timestamp":1559935279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-018-0854-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["854"],"URL":"https:\/\/doi.org\/10.1007\/s11906-018-0854-2","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"8 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"56"}}